Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 24, 2023, with respect to the consolidated financial statements of Diffusion Pharmaceuticals Inc., incorporated herein by reference.
/s/ KPMG LLP
McLean, Virginia
September 28, 2023